Merck melanoma drug shrinks tumors in 38 percent of patients

[riky]

Merck melanoma drug shrinks tumors in 38 percent of patients

<p><a href="http://news.yahoo.com/merck-melanoma-drug-shrinks-tumors-38-percent-patients-154718857.html"><img src="http://l1.yimg.com/bt/api/res/1.2/dvSLsYd92LNHvcjar0F2Tg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-06-02T154718Z_1_CBRE95117UX00_RTROPTP_2_SCHERINGPLOUGH-MERCK.JPG" width="130" height="86" alt="A view of the Merck &amp; Co. campus in Linden, New Jersey" align="left" title="A view of the Merck &amp; Co. campus in Linden, New Jersey" border="0" /></a>By Julie Steenhuysen CHICAGO (Reuters) - A Merck &amp; Co drug designed to unmask tumor cells and mobilize the immune system into fighting cancer helped shrink tumors in 38 percent of patients with advanced melanoma in an early-stage study, U.S. researchers said on Sunday. Based on the findings about the drug lambrolizumab, published in the New England Journal of Medicine and presented at the American Society of Clinical Oncology meeting in Chicago, Merck says it will move directly into a late-stage clinical trial, which will start in the third quarter. &quot;This is a top priority at Merck,&quot; Dr. ...</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login